Chemical Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Chemical Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$2.25M	Sell	12,263 -76	-0.6%	-$13.3K	0.26%	96
2019 Q1	$2.27M	Buy	12,339 +978	+9%	+$181K	0.26%	93
2018 Q4	$1.88M	Buy	11,361 +7,394	+186%	+$1.28M	0.23%	98
2018 Q3	$765K	Buy	3,967 +1,581	+66%	+$282K	0.08%	205
2018 Q2	$405K	Buy	+2,386	New	+$370K	0.04%	274

Other funds holding VRTX

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return